NCT00241137View on ClinicalTrials.gov

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

PHASE3CompletedINTERVENTIONAL
Enrollment

3,790

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Hypertension
Interventions
DRUG

valsartan

Trial Locations (1)

Unknown

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY